Scott Treiber, PhD, MBA
Executive Vice President, Biopharmaceutical Development and General Manager
A seasoned veteran with expertise in clinical operations, clinical development, medical affairs, data management, statistics and pharmacovigilance, Dr. Scott Treiber oversees all aspects of Chiltern’s biopharmaceutical development. His oversight encompasses early phase, first-in-human and proof-of-concept studies and Phase II-IV studies across a wide range of therapeutic areas, and he also provides executive oversight for our Latin America region. Before joining Chiltern, Treiber held director-level positions at Theorem, Premier Research, ICON and Quintiles. He was also vice president of clinical research for PharmaNet and vice president of global clinical operations and medical affairs for Hospira and held several executive-level positions at inVentiv Health Clinical. He is a founding member of the Clinical Research Exchange and is active in the Chicagoland Chapter of the Association of Clinical Research Professionals. He earned his bachelor’s degree from the University of Iowa, a PhD in biology from the University of California, Santa Cruz, and an MBA from Ellis College at the New York Institute of Technology. He is based near Chicago, Illinois.